Testing a new malaria vaccine in healthy adults
Treatments studied
Part of Infections clinical trials.
This study tests an experimental malaria vaccine (CVD 36000) in healthy volunteers aged 18–50. Researchers will give you the vaccine and later expose you to malaria parasites in a controlled setting to see if the vaccine protects you. This helps develop a safer vaccine for people in malaria-prone countries.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 50 years old and in good overall health
- You cannot be pregnant, breastfeeding, or planning to become pregnant for 10 months after the vaccine
- You must not have had malaria before or spent more than 6 months in a malaria-endemic area in the last 5 years
- You cannot have hepatitis B, hepatitis C, or HIV infection
- Your blood work and heart health must be normal, and you cannot take certain antibiotics or antimalarial medicines during the study
- You must be able to understand the study, pass a comprehension test, and follow all study instructions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new malaria vaccine called PfSPZ-LARC2 in healthy adults living in Burkina Faso. If you qualify, the vaccine is given to see if it can protect you from malaria.
This study tests a new malaria vaccine called PfSPZ-LARC2 in healthy adults. Participants will receive the vaccine and then be exposed to malaria to see if it protects them.
This study tests a new long-acting malaria prevention injection (MMV371) in healthy adults and adolescents in Rwanda. Researchers will monitor how safe it is and how your body processes it over 24 weeks.
This study tests an experimental malaria vaccine called PfSPZ-LARC2. Researchers want to learn if it is safe and effective for women who could become pregnant, especially in Mali where malaria is common. You would receive several doses of the vaccine and be followed for a few months.
This study screens healthy adults to see who can join future malaria vaccine or investigational malaria drug studies, including a controlled malaria exposure. It may help researchers test safer vaccines/drugs, but participation requires good health and strict medical eligibility.
This study gives healthy adults who have never had malaria a controlled infection with the parasite that causes malaria, to see if it is safe and if mosquitoes can pick up the parasite from them. It may help develop new ways to prevent malaria.
Hear when a new Malaria (Plasmodium Falciparum) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.